340B Expansion, Revisions Becoming Front-Burner Issues For Pharma
Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry
Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry